Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Regeneron Plunges 10% on Melanoma Drug Trial Failure
Regeneron Pharmaceuticals shares dropped 9.8% Monday after its late-stage melanoma drug trial with fianlimab failed to meet its primary endpoint, missing statistical significance versus Merck's Keytruda.
Sunshine Biopharma Shares Swing Wildly After $6M Offering
Sunshine Biopharma shares experienced extreme volatility Monday after a $6M public offering, surging 516% before closing up 78% at $0.51.
NextEra's $66.8B Dominion Deal Targets AI Data Center Demand
NextEra Energy agreed to acquire Dominion Energy in a $66.8B all-stock deal, sending Dominion shares up 9.4% as AI data centers drive power demand.
Goosehead Insurance Shares Surge 12% After JPMorgan Target Cut
Goosehead Insurance shares jumped 12% to $42.14, recovering from recent lows after JPMorgan cut its price target to $55. Q1 revenue rose 23% to $93.1M, with net income tripling.
DTE Energy Issues 1 GW Clean Power RFP, Michigan Developers Face 2029 Deadline
DTE Energy seeks 1 GW of renewable capacity in Michigan, with projects required to begin operations by end of 2029, aligning with state clean energy goals.
AMC Shares Rise 6.25% Amid Dilution Concerns and Menu Expansion
AMC Entertainment shares rose 6.25% to $1.36 on Monday, outpacing broader markets, but caution lingers due to dilution and debt concerns.
USA Rare Earth Plunges 12.8% as Defense Lobby Delays Chinese Magnet Ban
USA Rare Earth shares dropped 12.8% to $21.28 Monday after defense firms pushed to delay a ban on Chinese rare-earth magnets. The company posted $5.7M in Q1 revenue and received a $14.18M Texas grant.
Vertiv Shares Tumble 8.5% Ahead of Key Investor Conference
Vertiv Holdings shares dropped 8.5% to $339.41 on Monday, erasing over $12 billion in market value ahead of a key investor conference. The decline outpaced peers as U.S. tech stocks fell broadly.
